Subacute inflammatory polyradiculopathy associated with Sjögren's syndrome.
Peripheral nervous system involvement is common in Sjögren's syndrome (SS); however, polyradiculopathy has been reported rarely in association with SS, and predominantly chronic forms have been described. We describe a patient with clinical, cerebrospinal fluid, neurophysiological, and neuroradiological evidence of subacute inflammatory polyradiculopathy in whom Sjögren's syndrome was diagnosed after the onset of neurological symptoms. Our case suggests that SS should be included in the differential diagnosis of subacute inflammatory polyradiculopathy.
Rigamonti
Andrea
A
Neurological Department, Alessandro Manzoni General Hospital, Via Dell'Eremo 9/11, 23900 Lecco, Italy. rig74@libero.it
Lauria
Giuseppe
G
Balgera
Roberto
R
Agostoni
Elio
E
D000368:Aged; D018450:Disease Progression; D004568:Electrodiagnosis; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D018908:Muscle Weakness / Q000209:etiology; D009431:Neural Conduction / Q000276:immunology; D010292:Paresthesia / Q000209:etiology; D010525:Peripheral Nerves / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology*; D011241:Prednisone / Q000627:therapeutic use; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology*; D013126:Spinal Nerve Roots / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D011241:Prednisone; D008775:Methylprednisolone